Devyser’s Prenatal Chromosome Test Gets IVDR Certification
Devyser Compact is a rapid genetic test for prenatal chromosome testing and is approved under the new more comprehensive regulation.
Category: Prenatal Testing
Prenatal Testing
Latest
Prenatal Testing
Latest
Prenatal Test Developed for At-Risk Pregnancies
Veritas has created a new prenatal diagnostic test that can help identify fetal anomalies in at-risk pregnancies.
Prenatal Testing
Latest
Real-World Evidence Shows Cost Effectiveness of Offering NIPT to All Pregnant Women
Offering insurance coverage of non-invasive prenatal testing to all pregnant women increases utlilization at a cost of less than 3 cents per member per month.
Myriad’s Amplify Technology Improves Prequel NIPS Test
The Amplify process increases the fetal fraction of a NIPS sample by preferentially sequencing the fetal cell-free DNA fragments that circulate in a mother’s blood.
Read More
Novel Biomarker Discovery Could Lead to Early Diagnosis of Preeclampsia
The discovery of two novel biomarkers—FKBPL and CD44—has the potential to change the way preeclampsia is managed.
Read MoreBillionToOne Has Closed Its Follow-On Series A+ Funding Round of $15 Million
The new funding will be used to support commercial expansion of the company’s Unity prenatal screening test to all US states as well as research and development for future diagnostics.
Read More
Thermo Fisher Scientific and NX Prenatal Collaborate to Develop Fetal Health Assays
Thermo Fisher and NX Prenatal will develop clinical mass spectrometry-based workflows for monitoring maternal and fetal health during pregnancy, and evaluating the risk of complications.
Read More
First Customizable Noninvasive Prenatal Test for Single-Gene Disorders
The test broadens expectant parents’ prenatal testing options to include a safe, noninvasive test tailored to their family’s risk for a specific genetic disease.
Read More
Prenatal Screening Identifies More Couples at Risk for Birth Defects
The Foresight carrier screen identified 45% more couples at risk for having a child with cystic fibrosis than current guideline-based testing.
Read More
Next-Generation Multiplexing
A novel multiplexing platform called ‘high definition polymerase chain reaction’ brings together widely used, low-cost chemistries and qPCR instrumentation with proprietary data science algorithms to enable streamlined multiplex test development and very affordable test deliverables.
Read More
Parsortix Harvests Fetal Cells from the Blood of Pregnant Women
The Parsortix system offers the potential to extend NIPT to a wide range of conditions not feasible with existing techniques.
Read More
Study Validates Biomarker for Aneuploidy and Adverse Pregnancy Outcomes
Statisticians used data from more than a million Panorama tests to devise an algorithm that computes a fetal fraction-based risk score for pregnancy.
Read More
August/September Product News
This month’s Product News section features products from Qiagen, ELITechGroup Biomedical Systems, and DiaSorin Molecular.
Read More
Natera Announces New Clinical Utility Data and Issuance of CPT Code for NIPT in Twin Pregnancies
A noninvasive prenatal test for zygosity in twin pregnancies enables obstetricians to triage patients and avoid both overtreatment and undertreatment.
Read More
Qiagen, Natera Partner to Develop NGS Assays
For use on Qiagen’s next-generation sequencing system, the cell-free DNA assays will enable access to genetic testing, including prenatal screening, in hospitals and laboratories globally.
Read MoreIllumina, Harvard Pilgrim Expand Access to Next-Generation Sequencing for NIPT
Illumina has signed a contract with Harvard Pilgrim Health Care to accelerate patient access to next-generation sequencing for noninvasive prenatal testing.
Read More
BD Launches Blood Collection Tube for Cancer, Noninvasive Prenatal Testing Applications
The plastic blood collection tube incorporates a proprietary sample stabilization additive and BD Vacutainer Hemogard technology, and was designed to ensure accurate and reproducible results in molecular diagnostic testing applications using circulating cell-free DNA.
Read More
Natera’s Noninvasive Prenatal Test Now Available for Screening Twin Pregnancies
The Panorama noninvasive prenatal test is now validated to screen twin pregnancies for zygosity and chromosomal abnormalities.
Read More